Aryl hydrocarbon receptor agonist indigo protects against obesity-related insulin resistance through modulation of intestinal and metabolic tissue immunity

BACKGROUND/OBJECTIVES: Low-grade chronic inflammation in visceral adipose tissue and the intestines are important drivers of obesity associated insulin resistance. Bioactive compounds derived from plants are an important source of potential novel therapies for the treatment of chronic diseases. In s...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yi-Hsuan, Luck, Helen, Khan, Saad, Schneeberger, Pierre H. H., Tsai, Sue, Clemente-Casares, Xavier, Lei, Helena, Leu, Yann-Lii, Chan, Yi Tao, Chen, Hsing-Yu, Yang, Sien-Hung, Coburn, Bryan, Winer, Shawn, Winer, Daniel A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892742/
https://www.ncbi.nlm.nih.gov/pubmed/30944419
http://dx.doi.org/10.1038/s41366-019-0340-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892742/
https://www.ncbi.nlm.nih.gov/pubmed/30944419
http://dx.doi.org/10.1038/s41366-019-0340-1

Ejemplares similares